User profiles for "author:Thomas Pilgrim"
 | Thomas PilgrimBern University Hospital Verified email at insel.ch Cited by 31736 |
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT …
Background Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y 12 inhibitor prevents
ischaemic events after coronary stenting, but increases bleeding. Guidelines support …
ischaemic events after coronary stenting, but increases bleeding. Guidelines support …
Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review
TM Pilgrim, TR Wyss - International journal of cardiology, 2008 - Elsevier
BACKGROUND: Transient left ventricular apical ballooning syndrome (TLVABS) is an acute
cardiac syndrome mimicking ST-segment elevation myocardial infarction characterized by …
cardiac syndrome mimicking ST-segment elevation myocardial infarction characterized by …
Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis
Background: Atrioventricular (AV) conduction disturbances requiring permanent pacemaker
(PPM) implantation may complicate transcatheter aortic valve replacement (TAVR) …
(PPM) implantation may complicate transcatheter aortic valve replacement (TAVR) …
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis
GCM Siontis, P Overtchouk, TJ Cahill… - European heart …, 2019 - academic.oup.com
Aims Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients
with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter …
with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter …
[HTML][HTML] Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR
NM Van Mieghem, M Unverdorben… - … England Journal of …, 2021 - Mass Medical Soc
Background The role of direct oral anticoagulants as compared with vitamin K antagonists
for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not …
for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not …
Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography
M Taniwaki, MD Radu, S Zaugg, N Amabile… - Circulation, 2016 - Am Heart Assoc
Background—The pathomechanisms underlying very late stent thrombosis (VLST) after
implantation of drug-eluting stents (DES) are incompletely understood. Using optical …
implantation of drug-eluting stents (DES) are incompletely understood. Using optical …
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
SH Yoon, BK Whisenant, S Bleiziffer… - European heart …, 2019 - academic.oup.com
Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR)
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings …
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings …
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials
Aims In view of the currently available evidence from randomized trials, we aimed to
compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) …
compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) …
Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death
Importance Limited data exist on clinical characteristics and outcomes of patients who had
infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR) …
infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR) …
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation …
Background Refinements in stent design affecting strut thickness, surface polymer, and drug
release have improved clinical outcomes of drug-eluting stents. We aimed to compare the …
release have improved clinical outcomes of drug-eluting stents. We aimed to compare the …